Work Area: Valuation

Latest content

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

04 May 2022

Dealing with 5G disappointment

The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations

23 April 2022

The advantages of using hedonic regression to measure the value of standardised technologies

Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.

13 April 2022

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

04 April 2022

Five key takeaways from IPBC Europe

Returning from two action-packed days in London, IAM Deputy Editor Adam Houldsworth reflects on the surprising state of corporate UPC strategies, the rise of AI, FRAND fireworks and more

02 April 2022

Ocean Tomo acquired by global consulting firm J.S. Held

Two years after private equity buyout, the pioneering IP advisory firm led by Jim Malackowski changes hands again

30 March 2022

The brokered patent market in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

ROI’s latest report on sales activity and reflections on 10 years of market tracking

02 March 2022

The life science royalty sales market

Featured in Special Report 2022 Q1: Patent Dealmaking

Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products

02 March 2022

US patent assignments in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

Six things we learned about the transactions marketplace in a year that featured notable patent deals both big and small

02 March 2022

The brokered patent market in 2021

Featured in Secondary Market Activity

Richardson Oliver Insights highlights how the patent market has evolved to the point where it is not only a place to buy and sell assets.

02 March 2022

Unlock unlimited access to all IAM content